- Home
- OCUL vs MCRI Comparison
OCUL vs MCRI Comparison
Compare OCUL & MCRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUL
- MCRI
- Stock Information
- Founded
- OCUL 2006
- MCRI 1972
- Country
- OCUL United States
- MCRI United States
- Employees
- OCUL N/A
- MCRI N/A
- Industry
- OCUL Biotechnology: Pharmaceutical Preparations
- MCRI Hotels/Resorts
- Sector
- OCUL Health Care
- MCRI Consumer Discretionary
- Exchange
- OCUL Nasdaq
- MCRI Nasdaq
- Market Cap
- OCUL 1.8B
- MCRI 1.6B
- IPO Year
- OCUL 2014
- MCRI 1993
- Fundamental
- Price
- OCUL $11.92
- MCRI $101.50
- Analyst Decision
- OCUL Strong Buy
- MCRI Hold
- Analyst Count
- OCUL 7
- MCRI 5
- Target Price
- OCUL $17.33
- MCRI $96.20
- AVG Volume (30 Days)
- OCUL 2.0M
- MCRI 183.7K
- Earning Date
- OCUL 08-05-2025
- MCRI 07-16-2025
- Dividend Yield
- OCUL N/A
- MCRI 1.17%
- EPS Growth
- OCUL N/A
- MCRI N/A
- EPS
- OCUL N/A
- MCRI 4.22
- Revenue
- OCUL $59,647,000.00
- MCRI $534,693,999.00
- Revenue This Year
- OCUL N/A
- MCRI $6.37
- Revenue Next Year
- OCUL $20.85
- MCRI $4.55
- P/E Ratio
- OCUL N/A
- MCRI $24.42
- Revenue Growth
- OCUL N/A
- MCRI 4.65
- 52 Week Low
- OCUL $5.79
- MCRI $69.99
- 52 Week High
- OCUL $12.35
- MCRI $113.88
- Technical
- Relative Strength Index (RSI)
- OCUL 68.93
- MCRI 61.88
- Support Level
- OCUL $11.76
- MCRI $102.46
- Resistance Level
- OCUL $12.35
- MCRI $108.52
- Average True Range (ATR)
- OCUL 0.45
- MCRI 3.00
- MACD
- OCUL -0.07
- MCRI -0.21
- Stochastic Oscillator
- OCUL 69.93
- MCRI 56.13
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.